Q2 2024 |
4 |
$335M |
$0 |
-$52.6M |
-$52.6M |
CNTA, PHAT, NAMS, AURA
|
13F-HR |
7/16/2024, 04:31 PM |
Q1 2024 |
5 |
$449M |
+$39.3M |
-$19.4M |
+$19.9M |
CNTA, PHAT, NAMS, MRUS, AURA
|
13F-HR |
4/15/2024, 12:28 PM |
Q4 2023 |
5 |
$296M |
$0 |
-$53.5M |
-$53.5M |
CNTA, MRUS, PHAT, NAMS, AURA
|
13F-HR |
2/1/2024, 08:43 AM |
Q3 2023 |
6 |
$313M |
$0 |
-$13.5M |
-$13.5M |
CNTA, PCVX, PHAT, MRUS, AURA
|
13F-HR |
10/18/2023, 09:39 AM |
Q2 2023 |
6 |
$357M |
+$28.6M |
-$7.08M |
+$21.5M |
CNTA, PCVX, PHAT, MRUS, AURA
|
13F-HR |
7/19/2023, 11:04 AM |
Q1 2023 |
6 |
$233M |
$0 |
$0 |
|
CNTA, PCVX, MRUS, AURA, NAMS
|
13F-HR |
4/27/2023, 08:51 AM |
Q4 2022 |
6 |
$238M |
+$21.8M |
-$20.6M |
+$1.17M |
PCVX, CNTA, AURA, PHAT, MRUS
|
13F-HR |
1/31/2023, 04:16 PM |
Q3 2022 |
5 |
$240M |
+$372K |
-$2.53M |
-$2.16M |
CNTA, AURA, PCVX, MRUS, PHAT
|
13F-HR |
10/25/2022, 09:00 AM |
Q2 2022 |
6 |
$241M |
+$3.23M |
-$4.79M |
-$1.56M |
CNTA, AURA, PCVX, MRUS, PHAT
|
Restatement |
8/3/2022, 11:09 AM |
Q1 2022 |
7 |
$369M |
+$16.5M |
$0 |
+$16.5M |
CNTA, AURA, PCVX, MRUS, PHAT
|
13F-HR |
5/12/2022, 09:55 AM |
Q4 2021 |
7 |
$400M |
+$53.9M |
$0 |
+$53.9M |
CNTA, AURA, MRUS, PCVX, PHAT
|
13F-HR |
2/3/2022, 09:26 AM |
Q3 2021 |
6 |
$460M |
$0 |
$0 |
|
CNTA, PHAT, PCVX, MRUS, CMPI
|
13F-HR |
11/10/2021, 12:47 PM |
Q2 2021 |
6 |
$558M |
+$398M |
$0 |
+$398M |
CNTA, PHAT, PCVX, MRUS, CMPI
|
13F-HR |
8/3/2021, 06:15 AM |
Q1 2021 |
5 |
$172M |
$0 |
$0 |
|
PHAT, PCVX, MRUS, CMPI, OBSVF
|
13F-HR |
5/11/2021, 11:40 AM |
Q4 2020 |
5 |
$172M |
$0 |
$0 |
|
PHAT, PCVX, MRUS, CMPI, OBSVF
|
13F-HR |
2/12/2021, 08:49 AM |
Q3 2020 |
5 |
$209M |
+$17.3M |
$0 |
+$17.3M |
PCVX, PHAT, MRUS, CMPI, OBSVF
|
13F-HR |
10/27/2020, 11:30 AM |
Q2 2020 |
4 |
$163M |
+$59.7M |
$0 |
+$59.7M |
PHAT, PCVX, MRUS, OBSVF
|
13F-HR |
8/7/2020, 06:05 AM |
Q1 2020 |
3 |
$76.5M |
$0 |
-$70.3M |
-$70.3M |
PHAT, MRUS, OBSVF
|
13F-HR |
5/12/2020, 12:01 PM |
Q4 2019 |
4 |
$163M |
$0 |
$0 |
|
THOR, PHAT, MRUS, OBSVF
|
13F-HR |
2/11/2020, 09:40 AM |